Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulbactam PK/PD in Acinetobacter Infections
NCT02688322Phase 4Completed
- Start
- Sep 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sulbactam in Acinetobacter infection. Primary endpoint: Concentration of sulbactam in plasma at Day 4. Started Sep 2014; status: completed.
02
Drugs
sulbactam
03
Conditions
Acinetobacter infection
Beyond the preview
Go deeper on NCT02688322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02688322.